Safety and effectiveness of disease-modifying therapies after switching from natalizumab.
Mult Scler
; 30(8): 1026-1035, 2024 Jul.
Article
in En
| MEDLINE
| ID: mdl-39054846
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Leukoencephalopathy, Progressive Multifocal
/
JC Virus
/
Multiple Sclerosis, Relapsing-Remitting
/
Natalizumab
/
Immunologic Factors
Limits:
Adult
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Mult Scler
Journal subject:
NEUROLOGIA
Year:
2024
Document type:
Article
Affiliation country:
Francia
Country of publication:
Reino Unido